CleanCells

Executive Summary

CleanCells is a French contract manufacturing and testing organization (CMO/CRO) with over 15 years of expertise in cell and virus bank manufacturing and quality control (QC) testing for bioproducts. Founded in 2006 and headquartered in Nantes, the company supports biopharmaceutical clients from R&D through commercialization, ensuring compliance with global regulatory agencies. As the biologics and cell/gene therapy sectors expand, CleanCells is strategically positioned to offer reliable, high-quality manufacturing and testing services that meet the rigorous standards of the industry. Its focus on cell and virus banks—critical raw materials for many advanced therapies—underscores its niche but essential role in the bioprocessing value chain. Although the company remains private and has not publicly disclosed financials, its steady operation for nearly two decades suggests a resilient business model and growing demand for its specialized services.

Upcoming Catalysts (preview)

• Q4 2026Expansion of QC testing services into Asian markets60% success
• Q3 2026Partnership with a major gene therapy developer50% success
• Q1 2027Renewal or expansion of ISO/regulatory certifications80% success